⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tigit

Every month we try and update this database with for tigit cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced TumoursNCT05607563
Advanced Tumor
PM1009 injectio...
18 Years - 75 YearsBiotheus Inc.
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast CancerNCT05809895
Triple Negative...
Ociperlimab
Tislelizumab
Paclitaxel
Nab-paclitaxel
Carboplatin
Placebo
Pembrolizumab
Gemcitabine
18 Years - Novartis
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast CancerNCT05809895
Triple Negative...
Ociperlimab
Tislelizumab
Paclitaxel
Nab-paclitaxel
Carboplatin
Placebo
Pembrolizumab
Gemcitabine
18 Years - Novartis
Study of Novel Regimens in Relapsed or Refractory Multiple MyelomaNCT05289492
Multiple Myelom...
EOS884448
Iberdomide
Dexamethasone
18 Years - iTeos Therapeutics
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)NCT03739710
Neoplasms
Docetaxel
Feladilimab
Ipilimumab
GSK4428859A
Dostarlimab
GSK6097608
18 Years - GlaxoSmithKline
AB154 Combined With AB122 for Recurrent GlioblastomaNCT04656535
Glioblastoma
AB122
AB154
Placebo
18 Years - Yale University
Study of Novel Regimens in Relapsed or Refractory Multiple MyelomaNCT05289492
Multiple Myelom...
EOS884448
Iberdomide
Dexamethasone
18 Years - iTeos Therapeutics
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)NCT04585815
Carcinoma, Non-...
Sasanlimab Pref...
Encorafenib
Binimetinib
Sasanlimab
Axitinib
SEA-TGT
18 Years - Pfizer
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against CancersNCT03198052
Lung Cancer
Cancer
Immunotherapy
CAR-T Cell
CAR-T cells tar...
18 Years - 75 YearsSecond Affiliated Hospital of Guangzhou Medical University
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)NCT03739710
Neoplasms
Docetaxel
Feladilimab
Ipilimumab
GSK4428859A
Dostarlimab
GSK6097608
18 Years - GlaxoSmithKline
A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced TumoursNCT05607563
Advanced Tumor
PM1009 injectio...
18 Years - 75 YearsBiotheus Inc.
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid TumorsNCT05060432
Advanced Cancer
Lung Cancer
Head and Neck C...
Melanoma
EOS-448
pembrolizumab
inupadenant
Dostarlimab
SOC chemotherap...
18 Years - iTeos Therapeutics
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: